Reasons Patients With a Positive Fecal Occult Blood Test Result Do Not Undergo Complete Diagnostic Evaluation

被引:41
作者
Jimbo, Masahito [1 ]
Myers, Ronald E. [2 ]
Meyer, Birgit [1 ,3 ]
Hyslop, Terry [4 ]
Cocroft, James [2 ]
Turner, Barbara J. [5 ]
Weinberg, David S. [6 ]
机构
[1] Univ Michigan, Dept Family Med, Ann Arbor, MI 48109 USA
[2] Thomas Jefferson Univ, Dept Med Oncol, Philadelphia, PA 19107 USA
[3] Doernbecher Childrens Hosp, Portland, OR USA
[4] Thomas Jefferson Univ, Dept Pharmacol & Expt Therapeut, Div Biostat, Philadelphia, PA 19107 USA
[5] Univ Penn, Dept Med, Philadelphia, PA 19104 USA
[6] Fox Chase Canc Ctr, Dept Med Oncol, Philadelphia, PA 19111 USA
关键词
Colorectal neoplasm; occult blood/fecal; mass screening; follow-up studies; FOBT; AMERICAN-CANCER-SOCIETY; PRIMARY-CARE PHYSICIANS; COLORECTAL-CANCER; FOLLOW-UP; NATIONAL-SURVEY; UNITED-STATES; TASK-FORCE; SURVEILLANCE; GUIDELINES; RATIONALE;
D O I
10.1370/afm.906
中图分类号
R1 [预防医学、卫生学];
学科分类号
100235 [预防医学];
摘要
PURPOSE Screening for fecal occult blood reduces colorectal cancer mortality by identifying patients with positive results for complete diagnostic evaluation (CDE). CDE rates are suboptimal, however. We sought to determine common reasons for nonperformance of a CDE as recorded by the primary care physician. METHODS We undertook a descriptive analysis of reasons reported by physicians for nonperformance of CDE in a nested sample of patients with positive fecal occult blood test (FOBT) results from a randomized controlled trial designed to evaluate the impact of a physician intervention (CDE reminder-feedback and educational outreach) on recommendation and performance rates in primary care practices. Inspection of administrative data for 1,468 patients with positive results showed that 661 (45%) did not undergo CDE. We reviewed patient follow-up forms, which were completed by physicians for patients who did not have a CDE, to identify reasons for nonperformance. RESULTS Nonperformance of CDE was due to physician decision for 217 patients (33%). In 123 patients (19%), reasons for nonperformance were compatible with the guidelines, and in 94 patients (14%), they were not. Reasons wholly or partially due to factors other than physician decision were noted in 212 patients (32%); physician action was considered to be appropriate in these patients. For the 232 patients (35%) without a clearly documented reason for CDE nonperformance, the appropriateness of the physicians' action could not be determined. CONCLUSIONS Decision making by primary care physicians had a major effect on nonperformance of CDE after a positive FOBT result. Colorectal cancer screening programs should include guidance for physicians about when a CDE should and should not be performed.
引用
收藏
页码:11 / 16
页数:6
相关论文
共 29 条
[1]
[Anonymous], NCI STRAT PLAN LEAD
[2]
Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result [J].
Baig, N ;
Myers, RE ;
Turner, BJ ;
Grana, J ;
Rothermel, T ;
Schlackman, N ;
Weinberg, DS .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (09) :2078-2081
[3]
Screening for colorectal cancer: Recommendation and rationale [J].
Berg, AO ;
Allan, JD ;
Frame, PS ;
Homer, CJ ;
Johnson, MS ;
Klein, JD ;
Lieu, TA ;
Mulrow, CD ;
Orleans, CT ;
Peipert, JF ;
Pender, NJ ;
Siu, AL ;
Teutsch, SM ;
Westhoff, C ;
Woolf, SH .
ANNALS OF INTERNAL MEDICINE, 2002, 137 (02) :129-131
[4]
Measuring the quality of colorectal cancer screening: The importance of follow-up [J].
Etzioni, David A. ;
Yano, Elizabeth M. ;
Rubenstein, Lisa V. ;
Lee, Martin L. ;
Ko, Gifford Y. ;
Brook, Robert H. ;
Parkerton, Patricia H. ;
Asch, Steven M. .
DISEASES OF THE COLON & RECTUM, 2006, 49 (07) :1002-1010
[5]
Barriers to full colon evaluation for a positive fecal occult blood test [J].
Fisher, Deborah A. ;
Jeffreys, Amy ;
Coffman, Cynthia J. ;
Fasanella, Kenneth .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (06) :1232-1235
[6]
Colorectal cancer screening, comorbidity, and follow-up in elderly patients [J].
Garman, Katherine S. ;
Jeffreys, Amy ;
Coffman, Cynthia ;
Fisher, Deborah A. .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2006, 332 (04) :159-163
[7]
Asymptomatic chronic gastrointestinal blood loss in patients taking aspirin or warfarin for cardiovascular disease [J].
Greenberg, PD ;
Cello, JP ;
Rockey, DC .
AMERICAN JOURNAL OF MEDICINE, 1996, 100 (06) :598-604
[8]
Randomised controlled trial of faecal-occult-blood screening for colorectal cancer [J].
Hardcastle, JD ;
Chamberlain, JO ;
Robinson, MHE ;
Moss, SM ;
Amar, SS ;
Balfour, TW ;
James, PD ;
Mangham, CM .
LANCET, 1996, 348 (9040) :1472-1477
[9]
Fecal occult blood testing in a general medical clinic: Comparison between guaiac-based and immunochemical-based tests [J].
Ko, CW ;
Dominitz, JA ;
Nguyen, TD .
AMERICAN JOURNAL OF MEDICINE, 2003, 115 (02) :111-114
[10]
Randomised study of screening for colorectal cancer with faecal-occult-blood test [J].
Kronborg, O ;
Fenger, C ;
Olsen, J ;
Jorgensen, OD ;
Sondergaard, O .
LANCET, 1996, 348 (9040) :1467-1471